Citation Impact
Citing Papers
Platelet Granule Secretion Continuously Prevents Intratumor Hemorrhage
2008
Reduced activity of TAFI (thrombin‐activatable fibrinolysis inhibitor) in acute promyelocytic leukaemia
2000
The international normalized ratio according to Owren in liver disease: Interlaboratory assessment and determination of international sensitivity index
2013 StandoutNobel
The anti-invasive activity of synthetic alkaloid ethoxyfagaronine on L1210 leukemia cells is mediated by down-regulation of plasminogen activators and MT1-MMP expression and activity
2010 StandoutNobel
Use of arsenic trioxide (As2O3) in the treatment of patients with acute promyelocytic leukemia
2003 Standout
Annexin II and Bleeding in Acute Promyelocytic Leukemia
1999
Contribution of platelets to tumour metastasis
2011 Standout
Endovascular Mechanical Thrombectomy of an Occluded Superior Division Branch of the Left MCA for Acute Cardioembolic Stroke
2003
Increased expression of plasminogen activator and plasminogen activator inhibitor during liver fibrogenesis of rats: role of stellate cells
1999
Paraneoplastic Syndromes Involving the Nervous System
2003 Standout
Thrombin-Activatable Fibrinolysis Inhibitor Deficiency in Cirrhosis Is Not Associated With Increased Plasma Fibrinolysis
2001
Plasminogen activators and their inhibitors in non-small cell lung cancer. Low content of type 2 plasminogen activator inhibitor associated with tumor dissemination
1994
Platelets and acute cerebral infarction
2012 StandoutNobel
Intraluminal Thrombus has a Selective Influence on Matrix Metalloproteinases and Their Inhibitors (Tissue Inhibitors of Matrix Metalloproteinases) in the Wall of Abdominal Aortic Aneurysms
2012 StandoutNobel
Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome
2005 Standout
The "Retinoic Acid Syndrome" in Acute Promyelocytic Leukemia
1992 Standout
The Significance of Fibrin Binding by Plasminogen Activator Inhibitor 1 for the Mechanism of Tissue-type Plasminogen Activator-mediated Fibrinolysis
1995
Platelet transfusions reduce fibrinolysis but do not restore platelet function during trauma hemorrhage
2017
A review on the wettability of dental implant surfaces II: Biological and clinical aspects
2014 Standout
The Fibrinolytic System of the Vessel Wall and Its Role in the Control of Thrombosis
1990
Elevated levels of von Willebrand Factor in cirrhosis support platelet adhesion despite reduced functional capacity
2006 Standout
Hemostatic Alterations in Liver Disease: A Review on Pathophysiology, Clinical Consequences, and Treatment
2007
Platelet Activation and Atherothrombosis
2007 Standout
The urokinase-type plasminogen activator system in cancer metastasis: A review
1997 Standout
Activation of both coagulation and fibrinolysis in childhood hemolytic uremic syndrome
1998
The role of thrombin receptors PAR1 and PAR4 for PAI-1 storage, synthesis and secretion by human platelets
2012 StandoutNobel
Haemostatic abnormalities in patients with liver disease
2002
Fibrinolytic response to venous occlusion is decreased in patients after Kawasaki disease
2003
Mechanisms of Hepatic Fibrogenesis
2008 Standout
Adipokines: inflammation and the pleiotropic role of white adipose tissue
2004 Standout
The potential role of platelet microparticles in atherosclerosis
2005
The long-term effects of metoprolol and epanolol on tissue-type plasminogen activator and plasminogen activator inhibitor 1 in patients with ischaemic heart disease
1994
Thrombin During Cardiopulmonary Bypass
2006
Maspin is an angiogenesis inhibitor
2000 Standout
Plasminogen activation in human leukemia and in normal hematopoietic cells
1999
Acute Fibrinolysis Shutdown after Injury Occurs Frequently and Increases Mortality: A Multicenter Evaluation of 2,540 Severely Injured Patients
2016
The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition
2016 Standout
Hemostatic alterations in cancer patients
1992
Role of Plasminogen-Activator Inhibitor Type 1 in the Pathogenesis and Outcome of the Hemolytic Uremic Syndrome
1992
The Cell Adhesion Domain in Plasma Vitronectin Is Cryptic
1997
Engineered mutants of HGF/SF with reduced binding to heparan sulphate proteoglycans, decreased clearance and enhanced activity in vivo
1998 StandoutNobel
Plasminogen activator inhibitor-1 and haemostasis in obesity
2001
Platelet α-granules
1993
Helicobacter pyloriNeutrophil‐Activating Protein Stimulates Tissue Factor and Plasminogen Activator Inhibitor–2 Production by Human Blood Mononuclear Cells
2001
Viscoelastic measurements of platelet function, not fibrinogen function, predicts sensitivity to tissue‐type plasminogen activator in trauma patients
2015
Platelet-Rich Plasma: A Review of Biology and Applications in Plastic Surgery
2006 Standout
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association
2017 Standout
The pathogenesis of atherosclerosis: a perspective for the 1990s
1993 StandoutNature
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
2008 Standout
Thrombosis as an intravascular effector of innate immunity
2012 Standout
Intraluminal Thrombus Enhances Proteolysis in Abdominal Aortic Aneurysms
2006
Guidelines for the Early Management of Adults With Ischemic Stroke
2007 Standout
Platelets synthesize large amounts of active plasminogen activator inhibitor 1
2004
Effect of Anticoagulants in Colorimetric Assay for Basic Carboxypeptidases
2002 StandoutNobel
United States Multicenter Study of Arsenic Trioxide in Relapsed Acute Promyelocytic Leukemia
2001 Standout
2011 Update to The Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists Blood Conservation Clinical Practice Guidelines
2011 Standout
Reassessing the hemostatic disorder associated with acute promyelocytic leukemia [see comments]
1992
Serpin Structure, Mechanism, and Function
2002 Standout
Acute Promyelocytic Leukemia
1993
Platelets and platelet adhesion support angiogenesis while preventing excessive hemorrhage
2006
Factors contributing to increased vascular fibrinolytic activity in mongrel dogs.
1993
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Statement for Health Professionals From the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association
2004 Standout
Biological implications of a 3 å structure of dimeric antithrombin
1994
Pathogenesis ofHelicobacter pyloriInfection
2006 Standout
Expression and functional role of urokinase‐type plasminogen activator receptor in normal and acute leukaemic cells
1998
Subcutaneous and Visceral Adipose Tissue: Their Relation to the Metabolic Syndrome
2000 Standout
Chronic Thromboembolic Pulmonary Hypertension
2006 Standout
COAGULATION DISORDERS IN CANCER
1996
Annexins: From Structure to Function
2002 Standout
Coronary Plaque Disruption
1995 Standout
Hyperfibrinolysis Diagnosed by Rotational Thromboelastometry (ROTEM®) Is Associated with Higher Mortality in Patients with Severe Trauma
2011
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease
2004 Standout
Low-affinity heparin stimulates the inactivation of plasminogen activator inhibitor-1 by thrombin
1994
Endothelial cells in physiology and in the pathophysiology of vascular disorders.
1998 Standout
Tumors: Wounds That Do Not Heal
1986 Standout
The cellular and molecular biology of plasminogen activator inhibitor type-2
1995
Fibrinolytic Factors and the Risk of Myocardial Infarction or Sudden Death in Patients With Angina Pectoris
1996
Molecular Cloning and Partial Characterization of Rat Procarboxypeptidase R and Carboxypeptidase N
2000 StandoutNobel
C-Reactive Protein, a Sensitive Marker of Inflammation, Predicts Future Risk of Coronary Heart Disease in Initially Healthy Middle-Aged Men
1999 Standout
Endogenous fibrinolytic system in chronic large-vessel thromboembolic pulmonary hypertension.
1992
Mechanisms of Venous Thrombosis and Resolution
2008
Works of A Croll being referenced
Plasminogen activator inhibitor (PAI‐1) in plasma and platelets
1988
Tumour cell u‐PA as a cause of fibrinolytic bleeding in metastatic disease
1997
The bleeding disorder in acute promyelocytic leukaemia: fibrinolysis due to u‐PA rather than defibrination
1989
Lysis of Platelet‐rich Thrombi: The Role of PAI–1a
1992
Distribution of plasminogen activator inhibitor in normal liver, cirrhotic liver, and liver with metastases.
1994
The activity of plasminogen activator inhibitor-1 (PAI-1) of human platelet
1990
Complexing of tissue plasminogen activator with PAI-1, alpha 2- macroglobulin, and C1-inhibitor: studies in patients with defibrination and a fibrinolytic state after electroshock or complicated labor
1990
Complexing of tissue plasminogen activator with PAI-1, alpha 2- macroglobulin, and C1-inhibitor: studies in patients with defibrination and a fibrinolytic state after electroshock or complicated labor
1990
Tissue plasminogen activator, plasminogen activator inhibitors, and activator-inhibitor complex in liver disease.
1994
The Roles of α2-Antiplasmin and Plasminogen Activator Inhibitor 1 (PAI-1) in the Inhibition of Clot Lysis
1993
Proteins of the Fibrinolytic System in Human Thrombi
1996
The roles of alpha 2-antiplasmin and plasminogen activator inhibitor 1 (PAI-1) in the inhibition of clot lysis.
1993